central counterparties (CCP)

Quantifi Wins Best New Technology Product – Collateral Management at FOW Asia Awards

Tuesday, October 18, 2016

Quantifi has awarded ‘Best New Technology Product – Collateral Management’ at the FOW Asia Awards. FOW Awards are judged by a panel of industry experts drawn from across the market in a range of disciplines. The winners in the technology categories are companies that have launched new products or made enhancements to existing products that solved a problem creatively, opened up new possibilities, or changed the way participants approach the market. read more

The Dynamics Driving Capital Markets, London Conference, 2016

Tuesday, August 23, 2016
In today's environment market participants need to be able to navigate and respond to new regulatory processes and political change. Regulatory reform in the shape of EMIR, Dodd-Frank, MiFID and Basel are increasing the cost of capital, impacting... read more

Regulatory Initiatives Impacting Funding, Collateral, and Capital Costs

Thursday, July 7, 2016

Following the 2008 financial crisis, the banking sector witnessed a plethora of regulatory changes. While these regulatory prescriptions cover every dimension of the banking world, the OTC derivatives (OTCDs) market has borne the brunt due to the derivatives' opaque and complex nature. Read More

Quantifi Whitepaper Explores Cost of Trading and Clearing in the Wake of Margining

Tuesday, June 7, 2016

The whitepaper explores how recent regulations are affecting the OTC derivative markets in complex and interrelated ways, which in turn have changed the way firms do business. Over-the-counter (OTC) derivatives markets continue to be impacted by regulatory changes. These changes are increasing clearing costs and consequently trading costs, to an extent that could not have been anticipated by the market, given the complexity of these regulatory reforms. read more

Cost of Trading and Clearing OTC Derivatives in the Wake of Margining

Thursday, March 3, 2016

by Quantifi & Cognizant

Over-the-counter (OTC) derivatives markets continue to be impacted by regulatory changes. These changes are affecting the way financial institutions do business in multiple, interrelated ways. Rising capital requirements are impacting profitability and return on equity. Market participants are now being forced to clear standard OTC trades through Central Counterparties (CCPs) and will soon face margin requirements for the remaining, nonstandard, uncleared derivatives.

Quantifi Awarded Risk Management Software of the Year for Financial Risk

Wednesday, November 18, 2015

Recognised for being at the forefront of product and technology innovation, Quantifi has continued to make significant investment in R&D so that it can strategically address increased demand and better serve existing clients. Quantifi has also addressed key client issues with support for XVA, Central Counterparty Clearing (CCP), margin replication, OIS Discounting, regulatory reporting, PFE limit management, and funding costs analysis such as Funding Valuation Adjustment (FVA). read more

The Dynamics Driving OTC Markets, New York Conference, 2015

Tuesday, October 6, 2015
Regulations in the form of Basel lll, EMIR, Dodd-Frank, MiFID, IFRS and IOSCO have altered the structure of the OTC markets. This has led banks to focus on pricing and managing costs in a consistent fashion at a trade, desk and business level.... read more